METHYLDOPA AND HYDROCHLOROTHIAZIDE

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

60 API Suppliers, 31 USDMF, 24 CEP/COS, 7 JDMF, 10 EU WC, 17 KDMF, 19 NDC API, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

3607 FDF Dossiers, 878 FDA Orange Book, 1902 Europe, 229 Canada, 2 Australia, 202 South Africa, 394 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 25MG;25MG, TABLET;ORAL - 50MG;50MG, CAPSULE;ORAL - 25MG;37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG;37.5MG, TABLET;ORAL - 50MG;75MG, TABLET;ORAL - 10MG;25MG, TABLET;ORAL - 5MG;12.5MG, TABLET;ORAL - 12.5MG;10MG, TABLET;ORAL - 12.5MG;20MG, TABLET;ORAL - 25MG;20MG, TABLET;ORAL - 12.5MG;100MG, TABLET;ORAL - 12.5MG;50MG, TABLET;ORAL - 25MG;100MG, CAPSULE;ORAL - 12.5MG, TABLET;ORAL - 12.5MG;150MG, TABLET;ORAL - 12.5MG;300MG, TABLET;ORAL - 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 12.5MG;160MG, TABLET;ORAL - 12.5MG;320MG, TABLET;ORAL - 12.5MG;80MG, TABLET;ORAL - 25MG;160MG, TABLET;ORAL - 25MG;320MG, TABLET;ORAL - 16MG;12.5MG, TABLET;ORAL - 32MG;12.5MG, TABLET;ORAL - 32MG;25MG, TABLET;ORAL - 12.5MG;40MG, TABLET;ORAL - 12.5MG;80MG, TABLET;ORAL - 25MG;80MG, TABLET;ORAL - 12.5MG;20MG, TABLET;ORAL - 12.5MG;40MG, TABLET;ORAL - 25MG;40MG, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG, TABLET;ORAL - EQ 10MG BASE;25MG;160MG, TABLET;ORAL - EQ 10MG BASE;25MG;320MG, TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG, TABLET;ORAL - EQ 5MG BASE;25MG;160MG, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 3 Rochem International Inc, 25 SPI Pharma, 2 Seqens, 17 DKSH, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 14 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 4 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 39 BASF, 3 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 3 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 6 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 16 Seppic, 9 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 6 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

119 Fillers, Diluents & Binders, 62 Coating Systems & Additives, 59 Direct Compression, 50 Disintegrants & Superdisintegrants, 40 Granulation, 40 Solubilizers, 40 Thickeners and Stabilizers, 38 Controlled & Modified Release, 38 Lubricants & Glidants, 36 Film Formers & Plasticizers, 33 Topical, 31 Parenteral, 28 Taste Masking, 24 Co-Processed Excipients, 21 Chewable & Orodispersible Aids, 14 Emulsifying Agents, 10 API Stability Enhancers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 7 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 145 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 1837 Finished Drug Prices, 16 Annual Reports

MARKET PLACE

30 APIs, 18 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 3 JP, 3 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

METHYLDOPA AND HYDROCHLOROTHIAZIDE

Filters

FILTER :

filter Company Reset all filters

39 All

01 39SPI Pharma

filter Capability Reset all filters

filter Country Reset all filters

01

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Brand Name : Advantol 300

Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking

Excipient Details : Advantol® 300 is a DC pharmaceutical excipient used to create soft chewable or soft melt oral dosage forms & enables rapid product development.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Orodispersible Tablet, Tablet

Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking

Brand : ADVANTOL 300

Applications : Advantol® 300 is a DC pharmaceutical excipient used to create soft chewable or soft melt oral dosage forms & enables rapid product development.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

02

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Brand Name : Advantose FS95

Application : Chewable & Orodispersible Aids, Direct Compression, Taste Masking

Excipient Details : Advantose® FS95 is spray-dried fructose coprocessed with starch, is a highly compressible pharmaceutical excipient with chewable vitamin applications.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Fructose, Starch

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Fructose, Starch

Dosage Form : Orodispersible Tablet, Tablet

Category : Chewable & Orodispersible Aids, Direct Compression, Taste Masking

Brand : ADVANTOSE FS95

Applications : Advantose® FS95 is spray-dried fructose coprocessed with starch, is a highly compressible pharmaceutical excipient with chewable vitamin applications.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

03

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Brand Name : AHMC 0600

Application : Co-Processed Excipients

Excipient Details : AHMC 0600 is a co-processed aluminum hydroxide and magnesium carbonate powder used in immediate-relief antacid tablet formulation.

Pharmacopoeia Ref : NA

Technical Specs : Apparent Density: 0.30-0.40

Ingredient(s) : Aluminum Hydroxide Excipient, Magnesium Carbonate Excipient

Dosage Form : Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Aluminum Hydroxide Excipient, Magnesium Carbonate Excipient

Dosage Form : Tablet

Category : Co-Processed Excipients

Brand : AHMC 0600

Applications : AHMC 0600 is a co-processed aluminum hydroxide and magnesium carbonate powder used in immediate-relief antacid tablet formulation.

Pharmacopoeia Ref : NA

Technical Specs : Apparent Density: 0.30-0.40

Grade : Oral

04

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet, Orodispersible Tablet

Grade : Oral

Brand Name : Compressol SM

Application : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Taste Masking

Excipient Details : Compressol® SM, co-processed polyol, is a DC excipient of mannitol & sorbitol with superior compactibility, lower disintegration time & hygroscopicity

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol, Sorbitol

Dosage Form : Tablet, Orodispersible Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol, Sorbitol

Dosage Form : Tablet, Orodispersible Tablet

Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Taste Masking

Brand : COMPRESSOL SM

Applications : Compressol® SM, co-processed polyol, is a DC excipient of mannitol & sorbitol with superior compactibility, lower disintegration time & hygroscopicity

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

05

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Brand Name : CS90

Application : Chewable & Orodispersible Aids, Direct Compression, Taste Masking

Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.

Pharmacopoeia Ref : NA

Technical Specs : PSD D50: 150-175, Tapped Density: 0.85

Ingredient(s) : Calcium Carbonate Excipient, Starch

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Calcium Carbonate Excipient, Starch

Dosage Form : Orodispersible Tablet, Tablet

Category : Chewable & Orodispersible Aids, Direct Compression, Taste Masking

Brand : CS90

Applications : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.

Pharmacopoeia Ref : NA

Technical Specs : PSD D50: 150-175, Tapped Density: 0.85

Grade : Oral

06

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Brand Name : DC CoDried

Application : Chewable & Orodispersible Aids, Direct Compression

Excipient Details : DC CoDried Powders are pre-formulated, DC aluminum hydroxide & magnesium hydroxide products used in the manufacturing of chewable antacids tablets.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Aluminum Hydroxide Excipient, Magnesium Hydroxide Excipient

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Aluminum Hydroxide Excipient, Magnesium Hydroxide Excipient

Dosage Form : Orodispersible Tablet, Tablet

Category : Chewable & Orodispersible Aids, Direct Compression

Brand : DC CODRIED

Applications : DC CoDried Powders are pre-formulated, DC aluminum hydroxide & magnesium hydroxide products used in the manufacturing of chewable antacids tablets.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

07

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Brand Name : Effer-Soda

Application : API Stability Enhancers

Excipient Details : Effer-Soda is a surface modified sodium bicarbonate powder that eliminates formulation instability, expensive packaging & premature effervescence.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Sodium Bicarbonate Excipient

Dosage Form : Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Sodium Bicarbonate Excipient

Dosage Form : Tablet

Category : API Stability Enhancers

Brand : EFFER-SODA

Applications : Effer-Soda is a surface modified sodium bicarbonate powder that eliminates formulation instability, expensive packaging & premature effervescence.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

08

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Brand Name : Lubripharm SSF

Application : Chewable & Orodispersible Aids, Lubricants & Glidants

Excipient Details : Lubripharm® Sodium Stearyl Fumarate (SSF) is a tablet lubricant used in orally disintegrating tablets (ODTs) and effervescent formulations.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Sodium Stearyl Fumarate

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Sodium Stearyl Fumarate

Dosage Form : Orodispersible Tablet, Tablet

Category : Chewable & Orodispersible Aids, Lubricants & Glidants

Brand : LUBRIPHARM SSF

Applications : Lubripharm® Sodium Stearyl Fumarate (SSF) is a tablet lubricant used in orally disintegrating tablets (ODTs) and effervescent formulations.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

09

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Brand Name : Magnesium Hydroxide 5100

Application : Granulation

Excipient Details : Magnesium Hydroxide powder 5100 is used in wet granulation tableting applications for the production of antacid tablets and digestive aids.

Pharmacopoeia Ref : USP, EP

Technical Specs : Tapped Density: 0.68-0.84

Ingredient(s) : Magnesium Hydroxide Excipient

Dosage Form : Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Magnesium Hydroxide Excipient

Dosage Form : Tablet

Category : Granulation

Brand : MAGNESIUM HYDROXIDE 5100

Applications : Magnesium Hydroxide powder 5100 is used in wet granulation tableting applications for the production of antacid tablets and digestive aids.

Pharmacopoeia Ref : USP, EP

Technical Specs : Tapped Density: 0.68-0.84

Grade : Oral

10

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Brand Name : Magnesium Hydroxide 5300

Application : Granulation

Excipient Details : Magnesium Hydroxide powder 5300 is used in wet granulation tableting applications for the production of antacid tablets and digestive aids.

Pharmacopoeia Ref : USP, EP

Technical Specs : Tapped Density: 0.60-0.90

Ingredient(s) : Magnesium Hydroxide Excipient

Dosage Form : Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Magnesium Hydroxide Excipient

Dosage Form : Tablet

Category : Granulation

Brand : MAGNESIUM HYDROXIDE 5300

Applications : Magnesium Hydroxide powder 5300 is used in wet granulation tableting applications for the production of antacid tablets and digestive aids.

Pharmacopoeia Ref : USP, EP

Technical Specs : Tapped Density: 0.60-0.90

Grade : Oral

11

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Brand Name : Mannogem EZ Spray-Dried

Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders

Excipient Details : Mannogem EZ Spray-Dried, a mannitol product, dissolves rapidly and can increase the rate of tablet disintegration, drug dissolution & drug release.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Orodispersible Tablet, Tablet

Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders

Brand : MANNOGEM EZ SPRAY-DRIED

Applications : Mannogem EZ Spray-Dried, a mannitol product, dissolves rapidly and can increase the rate of tablet disintegration, drug dissolution & drug release.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

12

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Brand Name : Mannogem Granular

Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders

Excipient Details : Mannogem Granular (mannitol) dissolves rapidly and can increase the rate of tablet disintegration, subsequent drug dissolution and drug release.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Orodispersible Tablet, Tablet

Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders

Brand : MANNOGEM GRANULAR

Applications : Mannogem Granular (mannitol) dissolves rapidly and can increase the rate of tablet disintegration, subsequent drug dissolution and drug release.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

13

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Granule / Pellet, Tablet

Grade : Oral

Brand Name : Mannogem Powder

Application : Fillers, Diluents & Binders, Granulation

Excipient Details : Mannogem (mannitol powder) is a pharmaceutical excipient that dissolves rapidly and increases tablet disintegration rate, drug dissolution & release.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol

Dosage Form : Granule / Pellet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Granule / Pellet, Tablet

Category : Fillers, Diluents & Binders, Granulation

Brand : MANNOGEM POWDER

Applications : Mannogem (mannitol powder) is a pharmaceutical excipient that dissolves rapidly and increases tablet disintegration rate, drug dissolution & release.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

14

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet, Orodispersible Tablet

Grade : Oral

Brand Name : Mannogem XL Mannitol

Application : API Stability Enhancers, Chewable & Orodispersible Aids, Fillers, Diluents & Binders

Excipient Details : Mannogem® XL is a DC spray-dried mannitol used to enhance mannitol formulation tabletability & provide superior binding & quick disintegration.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol

Dosage Form : Tablet, Orodispersible Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Tablet, Orodispersible Tablet

Category : API Stability Enhancers, Chewable & Orodispersible Aids, Fillers, Diluents & Binders

Brand : MANNOGEM XL MANNITOL

Applications : Mannogem® XL is a DC spray-dried mannitol used to enhance mannitol formulation tabletability & provide superior binding & quick disintegration.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

15

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Brand Name : Mannogem® Emerald

Application : Taste Masking

Excipient Details : Mannogem Emerald is a compendial, powder mannitol dissolves quickly, delivering excellent palatability through a creamy texture and mild sweetness.

Pharmacopoeia Ref : NA

Technical Specs : 25 µm Powder Mannitol

Ingredient(s) : Mannitol

Dosage Form : Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Tablet

Category : Taste Masking

Brand : MANNOGEM® EMERALD

Applications : Mannogem Emerald is a compendial, powder mannitol dissolves quickly, delivering excellent palatability through a creamy texture and mild sweetness.

Pharmacopoeia Ref : NA

Technical Specs : 25 µm Powder Mannitol

Grade : Oral

16

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Brand Name : Mannogem® Onyx

Application : Fillers, Diluents & Binders

Excipient Details : Mannogem® Onyx is a compendial, powder mannitol has reduced sensitivity to lubricants, low friability, and high binding capacity.

Pharmacopoeia Ref : NA

Technical Specs : 50 µm Powder Mannitol

Ingredient(s) : Mannitol

Dosage Form : Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Tablet

Category : Fillers, Diluents & Binders

Brand : MANNOGEM® ONYX

Applications : Mannogem® Onyx is a compendial, powder mannitol has reduced sensitivity to lubricants, low friability, and high binding capacity.

Pharmacopoeia Ref : NA

Technical Specs : 50 µm Powder Mannitol

Grade : Oral

17

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Brand Name : Mannogem® XL Opal

Application : Direct Compression, Fillers, Diluents & Binders, Taste Masking

Excipient Details : Mannogem® XL Opal, directly compressible 160 µm spray-dried mannitol provides superior binding properties and tabletability.

Pharmacopoeia Ref : NA

Technical Specs : 160 µm Powder Mannitol

Ingredient(s) : Mannitol

Dosage Form : Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Tablet

Category : Direct Compression, Fillers, Diluents & Binders, Taste Masking

Brand : MANNOGEM® XL OPAL

Applications : Mannogem® XL Opal, directly compressible 160 µm spray-dried mannitol provides superior binding properties and tabletability.

Pharmacopoeia Ref : NA

Technical Specs : 160 µm Powder Mannitol

Grade : Oral

18

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Brand Name : Mannogem® XL Ruby

Application : Chewable & Orodispersible Aids, Taste Masking

Excipient Details : Mannogem XL Ruby, granular mannitol used in pressure-sensitive, taste-masked APIs provides excellent tabletability in chewable tablets & soft-chews.

Pharmacopoeia Ref : NA

Technical Specs : 300 µm Granular Mannitol

Ingredient(s) : Mannitol

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Orodispersible Tablet, Tablet

Category : Chewable & Orodispersible Aids, Taste Masking

Brand : MANNOGEM® XL RUBY

Applications : Mannogem XL Ruby, granular mannitol used in pressure-sensitive, taste-masked APIs provides excellent tabletability in chewable tablets & soft-chews.

Pharmacopoeia Ref : NA

Technical Specs : 300 µm Granular Mannitol

Grade : Oral

19

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Brand Name : MS90

Application : Chewable & Orodispersible Aids, Direct Compression, Taste Masking

Excipient Details : MS90 is a directly compressible magnesium hydroxide with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.

Pharmacopoeia Ref : NA

Technical Specs : PSD D50: 150-170, Taped Density: 0.80

Ingredient(s) : Magnesium Hydroxide Excipient, Starch

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Magnesium Hydroxide Excipient, Starch

Dosage Form : Orodispersible Tablet, Tablet

Category : Chewable & Orodispersible Aids, Direct Compression, Taste Masking

Brand : MS90

Applications : MS90 is a directly compressible magnesium hydroxide with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.

Pharmacopoeia Ref : NA

Technical Specs : PSD D50: 150-170, Taped Density: 0.80

Grade : Oral

20

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Brand Name : Pharmaburst 500

Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking

Excipient Details : Pharmaburst® 500 is a directly compressible pharmaceutical excipient used to create orally disintegrating tablets quickly and easily.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Orodispersible Tablet, Tablet

Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking

Brand : PHARMABURST 500

Applications : Pharmaburst® 500 is a directly compressible pharmaceutical excipient used to create orally disintegrating tablets quickly and easily.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

21

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Brand Name : Pharmasperse 416

Application : Chewable & Orodispersible Aids, Taste Masking

Excipient Details : Pharmasperse® 416 is a versatile DDS comprised of mannitol excipients and is specifically engineered for orally dispersible powder (ODP) formulations.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Orodispersible Tablet, Tablet

Category : Chewable & Orodispersible Aids, Taste Masking

Brand : PHARMASPERSE 416

Applications : Pharmasperse® 416 is a versatile DDS comprised of mannitol excipients and is specifically engineered for orally dispersible powder (ODP) formulations.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

22

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Brand Name : DC SIM 100

Application : Direct Compression

Excipient Details : DC SIM 100 is a directly compressible simethicone powder used for antacid and anti-gas tablets.

Pharmacopoeia Ref : NA

Technical Specs : PSD D50: 50

Ingredient(s) : Simethicone Excipient

Dosage Form : Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Simethicone Excipient

Dosage Form : Tablet

Category : Direct Compression

Brand : DC SIM 100

Applications : DC SIM 100 is a directly compressible simethicone powder used for antacid and anti-gas tablets.

Pharmacopoeia Ref : NA

Technical Specs : PSD D50: 50

Grade : Oral

23

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Softgels

Grade : Oral

Brand Name : Sorbitol Special

Application : Film Formers & Plasticizers

Excipient Details : Sorbitol Special® is a plasticizer for soft gel formulations that reduces drying time and enhances productivity & gloss for a premium appearance.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Sorbitan Excipient, Sorbitol

Dosage Form : Softgels

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Sorbitan Excipient, Sorbitol

Dosage Form : Softgels

Category : Film Formers & Plasticizers

Brand : SORBITOL SPECIAL

Applications : Sorbitol Special® is a plasticizer for soft gel formulations that reduces drying time and enhances productivity & gloss for a premium appearance.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

24

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Brand Name : AHMC 0611

Application : Co-Processed Excipients

Excipient Details : AHMC 0611 is a co-processed aluminum hydroxide & magnesium carbonate micronized powder used in immediate-relief antacid tablets & liquid suspensions.

Pharmacopoeia Ref : NA

Technical Specs : Tapped NMT: 0.2

Ingredient(s) : Aluminum Hydroxide Excipient, Magnesium Carbonate Excipient

Dosage Form : Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Aluminum Hydroxide Excipient, Magnesium Carbonate Excipient

Dosage Form : Tablet

Category : Co-Processed Excipients

Brand : AHMC 0611

Applications : AHMC 0611 is a co-processed aluminum hydroxide & magnesium carbonate micronized powder used in immediate-relief antacid tablets & liquid suspensions.

Pharmacopoeia Ref : NA

Technical Specs : Tapped NMT: 0.2

Grade : Oral

25

SPI Pharma

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Brand Name : ACTILLETS

Application : Coating Systems & Additives

Excipient Details : ACTILLETS™ are microcrystalline cellulose spheres used in advanced drug formulations as starter cores for drug layering and coating.

Pharmacopoeia Ref : NA

Technical Specs : Bulk density: 0.80

Ingredient(s) : Microcrystalline Cellulose

Dosage Form : Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Microcrystalline Cellulose

Dosage Form : Tablet

Category : Coating Systems & Additives

Brand : ACTILLETS

Applications : ACTILLETS™ are microcrystalline cellulose spheres used in advanced drug formulations as starter cores for drug layering and coating.

Pharmacopoeia Ref : NA

Technical Specs : Bulk density: 0.80

Grade : Oral

Looking for Pharmaceutical Excipients offered by SPI Pharma? Find METHYLDOPA AND HYDROCHLOROTHIAZIDE to address your drug delivery challenges on PharmaCompass.

METHYLDOPA AND HYDROCHLOROTHIAZIDE

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

60 API Suppliers

31 USDMF

24 CEP/COS

7 JDMF

10 EU WC

17 KDMF

19 NDC API

28 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

INTERMEDIATES

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

3607 FDF Dossiers

878 FDA Orange Book

1902 Europe

229 Canada

2 Australia

202 South Africa

394 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 25MG;25MG

TABLET;ORAL - 50MG;50MG

CAPSULE;ORAL - 25MG;37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 25MG;37.5MG

TABLET;ORAL - 50MG;75MG

TABLET;ORAL - 10MG;25MG

TABLET;ORAL - 5MG;12.5MG

TABLET;ORAL - 12.5MG;10MG

TABLET;ORAL - 12.5MG;20MG

TABLET;ORAL - 25MG;20MG

TABLET;ORAL - 12.5MG;100MG

TABLET;ORAL - 12.5MG;50MG

TABLET;ORAL - 25MG;100MG

CAPSULE;ORAL - 12.5MG

TABLET;ORAL - 12.5MG;150MG

TABLET;ORAL - 12.5MG;300MG

TABLET;ORAL - 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 12.5MG;160MG

TABLET;ORAL - 12.5MG;320MG

TABLET;ORAL - 12.5MG;80MG

TABLET;ORAL - 25MG;160MG

TABLET;ORAL - 25MG;320MG

TABLET;ORAL - 16MG;12.5MG

TABLET;ORAL - 32MG;12.5MG

TABLET;ORAL - 32MG;25MG

TABLET;ORAL - 12.5MG;40MG

TABLET;ORAL - 12.5MG;80MG

TABLET;ORAL - 25MG;80MG

TABLET;ORAL - 12.5MG;20MG

TABLET;ORAL - 12.5MG;40MG

TABLET;ORAL - 25MG;40MG

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG

TABLET;ORAL - EQ 10MG BASE;25MG;160MG

TABLET;ORAL - EQ 10MG BASE;25MG;320MG

TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG

TABLET;ORAL - EQ 5MG BASE;25MG;160MG

TABLET;ORAL - 25MG

TABLET;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

1 Minakem

1 Evonik

3 Rochem International Inc

25 SPI Pharma

CAPSULE;ORAL - 25MG;37.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 12.5MG;75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 25MG;300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 150MG BASE;12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 150MG BASE;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 300MG BASE;12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 300MG BASE;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons